These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1013313)

  • 1. [Changes in the lymphoid population of the bone marrow under the influence of radiomimetics].
    Barakina NF; Khao Iu; Rakhmanina ON
    Radiobiologiia; 1976; 16(2):284-7. PubMed ID: 1013313
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of rat bone marrow cells after treatment with myleran and endoxan.
    Dunjic A; Cuvelier AM
    Exp Hematol; 1973; 1(1):11-21. PubMed ID: 4608438
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
    Basch RS; Quito FL; Beh J; Hirst JA
    Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effect of four cytotoxic agents on granulocytic and erythroid repopulating ability of rat bone marrow.
    Constable TB; Blackett NM
    J Natl Cancer Inst; 1972 Apr; 48(4):941-8. PubMed ID: 4554117
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between granulocytic and erythroid repopulating ability.
    Constable TB; Blackett NM
    Exp Hematol; 1974; 2(3):131-7. PubMed ID: 4616841
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenetic aspects of marrow cell transplantation in rats after administration of myleran].
    Dunjic A; Linchet G; Cuvelier AM
    Pathol Biol (Paris); 1970 Oct; 18(19):871-80. PubMed ID: 4922807
    [No Abstract]   [Full Text] [Related]  

  • 8. "Stromal" and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice.
    Hays EF; Hale L; Villarreal B; Fitchen JH
    Exp Hematol; 1982 Apr; 10(4):383-92. PubMed ID: 7095015
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of prolonged corticoid treatment on the lymphoid cell population of irradiated bone marrow].
    Schmitz A; Haot J
    C R Seances Soc Biol Fil; 1971; 165(5):1186-8. PubMed ID: 4261508
    [No Abstract]   [Full Text] [Related]  

  • 10. The chemical and biological properties of busulphan ("Myleran").
    Dunn CD
    Exp Hematol; 1974; 2(3):101-17. PubMed ID: 4616840
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the effects of ionizing radiation and cyclophosphamide on the bone marrow of mice, by counting non-nucleated and nucleated cells].
    Segreto RA; Segreto HR; Silva MR; Novo NF; Sasso Wda S
    Rev Paul Med; 1989; 107(4-6):233-8. PubMed ID: 2701192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of combined cytoxic agents on the bone marrow].
    Maisin H
    C R Seances Soc Biol Fil; 1966; 160(8):1740-4. PubMed ID: 4227904
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
    Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
    Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of marrow stem cells in irradiated and non-irradiated mice after treatment with cytotoxic agents.
    Berman I; McCabe B; Dauer MM
    Radiat Res; 1969 May; 38(2):296-306. PubMed ID: 4977149
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative and immunosuppressive properties of treosulfan in mice.
    Sjöö F; Hassan Z; Abedi-Valugerdi M; Griskevicius L; Nilsson C; Remberger M; Aschan J; Concha H; Gaughan U; Hassan M
    Exp Hematol; 2006 Jan; 34(1):115-21. PubMed ID: 16413398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mylecytan-sensitive and Mylecytan-resistant strains of inbred SPF mice.
    Láznicka M
    Czech Med; 1980; 3(3):232-8. PubMed ID: 7438944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison in vivo of the clastogenic properties of busulfan and cyclophosphamide].
    Léonard A; Deknudt G
    C R Seances Soc Biol Fil; 1983; 177(2):239-42. PubMed ID: 6224545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marrow repopulation in mice treated with busulphan or isopropyl methane sulphonate and bone marrow.
    Massa G; Wyllie JP; Pratt AM; Molineux G; Schofield R
    Br J Haematol; 1987 May; 66(1):11-4. PubMed ID: 3036195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemopoietic spleen colonies in rats treated with cytotoxic drugs.
    Dunn CD; Elson LA
    Rev Fr Etud Clin Biol; 1969 Jan; 14(1):57-9. PubMed ID: 5784820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.